The toxins of Bacteroides fragilis.

Bacteroides fragilis are both key commensals and important human pathogens. Particular strains of B. fragilis, termed enterotoxigenic B. fragilis (ETBF), are recently identified enteric pathogens of children and adults. These strains are distinguished by secretion of a 20kDa metalloprotease toxin (B. fragilis toxin or BFT), the first recognized and only established toxin to date for B. fragilis. Three isotypes of BFT are encoded by distinct bft loci contained within a 6kb chromosomal region unique to ETBF strains termed the B. fragilis pathogenicity island (BfPAI). Experimental studies have suggested that the cellular target for BFT is E-cadherin, the primary protein of the zonula adherens. It is postulated that BFT cleavage of E-cadherin is critical in precipitating the intracellular events culminating in the two established activities for BFT; namely, stimulation of secretion in ligated intestinal segments in several animal species and alteration of cellular morphology only in epithelial cells that retain the ability to polarize and form a tight junctional complex. Future studies will be directed to characterizing in greater detail both the molecular genetics of the BFT toxin and the precise steps in its cellular mechanism of action.

[1]  C. Sears,et al.  Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Sansom,et al.  Properties of ion channels formed by Staphylococcus aureus δ-toxin , 1988 .

[3]  A. Franco,et al.  Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene , 1997, Infection and immunity.

[4]  A. Franco,et al.  Identification of a Third Metalloprotease Toxin Gene in Extraintestinal Isolates of Bacteroides fragilis , 1999, Infection and Immunity.

[5]  M. Inouye.  Intramolecular chaperone: the role of the pro-peptide in protein folding. , 1991, Enzyme.

[6]  T. Wilkins,et al.  Production of antisera against the enterotoxin of Bacteroides fragilis and their use in a cytotoxicity neutralization assay of HT-29 cells. , 1994, Clinical and diagnostic laboratory immunology.

[7]  Shaoguang Wu,et al.  Bacteroides fragilis toxin rearranges the actin cytoskeleton of HT29/C1 cells without direct proteolysis of actin or decrease in F-actin content. , 1997, Cell motility and the cytoskeleton.

[8]  H. Kato,et al.  Association of enterotoxigenic Bacteroides fragilis with bacteremia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Franco,et al.  Modulation of bft expression by the Bacteroides fragilis pathogenicity island and its flanking region , 2002, Molecular microbiology.

[10]  D. Clark,et al.  Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro , 1997, Infection and immunity.

[11]  J. Rice,et al.  Ion channel formation by synthetic analogues of staphylococcal delta-toxin. , 1995, Biochimica et biophysica acta.

[12]  R. Sack,et al.  Advances in Research on Cholera and Related Diarrheas , 1983, New Perspectives in Clinical Microbiology.

[13]  C. Sears,et al.  Bacteroides fragilis toxin rapidly intoxicates human intestinal epithelial cells (HT29/C1) in vitro , 1996, Infection and immunity.

[14]  Kunitomo Watanabe,et al.  Prevalence of Enterotoxigenic Bacteroides fragilis in Children with Diarrhea in Japan , 1999, Journal of Clinical Microbiology.

[15]  C. Sears,et al.  Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis , 1996, Infection and immunity.

[16]  Leeds Ca.  Pathogenicity islands and the evolution of bacterial pathogens. , 1996 .

[17]  A. J. Duncan,et al.  Molecular Characterization of the Fragilysin Pathogenicity Islet of Enterotoxigenic Bacteroides fragilis , 1998, Infection and Immunity.

[18]  R. Sack,et al.  Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study , 1994, Journal of clinical microbiology.

[19]  T. McDaniel,et al.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Weintraub,et al.  Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Pantosti,et al.  Detection of Bacteroides fragilis enterotoxin in the feces of a child with diarrhea. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Brazier,et al.  Medical and Environmental Aspects of Anaerobes , 1992 .

[23]  T. Wilkins,et al.  The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells , 1997, Infection and immunity.

[24]  J Hacker,et al.  Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution , 1997, Molecular microbiology.

[25]  D. Snydman,et al.  Attributable mortality of bacteremia associated with the Bacteroides fragilis group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Erlandsen,et al.  Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. , 1996, Gastroenterology.

[27]  B. Polk,et al.  Bacteroides fragilis subspecies in clinical isolates. , 1977, Annals of internal medicine.

[28]  A. Franco,et al.  Molecular Evolution of the Pathogenicity Island of Enterotoxigenic Bacteroides fragilis Strains , 1999, Journal of bacteriology.

[29]  W. Moore,et al.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians. , 1974, Applied microbiology.

[30]  D. S. Shoop,et al.  Association of Enterotoxigenic Bacteroides fragilis with Diarrheal Disease in Calves , 1985, The Journal of infectious diseases.

[31]  J. Kaper,et al.  Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Wilkins,et al.  The enterotoxin of Bacteroides fragilis is a metalloprotease , 1995, Infection and immunity.

[33]  M. Marinaro,et al.  Zonula Occludens Toxin Is a Powerful Mucosal Adjuvant for Intranasally Delivered Antigens , 1999, Infection and Immunity.

[34]  M. Menozzi,et al.  Bacteroides fragilis enterotoxin induces the expression of IL‐8 and transforming growth factor‐beta (TGF‐β) by human colonic epithelial cells , 2000, Clinical and experimental immunology.

[35]  A. Fasano,et al.  Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. , 1997, The Journal of clinical investigation.

[36]  D. Ohman,et al.  The elastase propeptide functions as an intramolecular chaperone required for elastase activity and secretion in Pseudomonas aeruginosa , 1995, Molecular microbiology.

[37]  C. Sears,et al.  Association of Bacteroides fragilis with childhood diarrhea. , 1995, Scandinavian journal of infectious diseases.

[38]  J. Kaper,et al.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Pantosti,et al.  The Alleles of the bft Gene Are Distributed Differently among Enterotoxigenic Bacteroides fragilis Strains from Human Sources and Can Be Present in Double Copies , 2000, Journal of Clinical Microbiology.

[40]  C. Fiorentini,et al.  Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells , 1996, Infection and immunity.

[41]  T. Wilkins,et al.  Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo , 1995, Infection and immunity.

[42]  C. L. Sears,et al.  Enterotoxigenic Bacteroides fragilis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[44]  D. Bevan,et al.  Molecular modeling and analysis of fragilysin, the Bacteroides fragilis toxin. , 1997, Clinical Infectious Diseases.

[45]  C. Fiorentini,et al.  Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. , 1995, The Journal of clinical investigation.

[46]  J. Silva,et al.  Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. , 2000, Emerging infectious diseases.

[47]  R. Sack,et al.  Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology , 1992, Infection and immunity.

[48]  J. Kaper,et al.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.

[49]  C. Pothoulakis,et al.  Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro , 1999, Gut.

[50]  D. Snydman,et al.  Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  T. Wilkins,et al.  Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. , 1997, FEMS microbiology letters.

[52]  H. Kato,et al.  A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan. , 2000, FEMS microbiology letters.

[53]  R. Sack,et al.  Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen. , 1992, Journal of diarrhoeal diseases research.

[54]  M. Wilm,et al.  The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.

[55]  T. Wilkins,et al.  Characterization of enterotoxigenic Bacteroides fragilis by a toxin-specific enzyme-linked immunosorbent assay. , 1994, Clinical and Diagnostic Laboratory Immunology.

[56]  A. Weintraub,et al.  Prevalence and Antimicrobial Susceptibility of Enterotoxigenic Bacteroides fragilis in Children with Diarrhoea in Nicaragua , 2000 .

[57]  T. Wilkins,et al.  Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route. , 2000, Vaccine.

[58]  L. L. Myers,et al.  Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs , 1984, Infection and immunity.

[59]  The structure of Escherichia coli heat‐stable enterotoxin b by nuclear magnetic resonance and circular dichroism , 1995, Protein science : a publication of the Protein Society.

[60]  C. Sears,et al.  Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Cossart,et al.  E-Cadherin Is the Receptor for Internalin, a Surface Protein Required for Entry of L. monocytogenes into Epithelial Cells , 1996, Cell.

[62]  J. Collins,et al.  Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits , 1989, Journal of clinical microbiology.

[63]  R. Sack,et al.  Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea , 1987, Journal of clinical microbiology.

[64]  A. Pantosti,et al.  Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.